Ixempra: cost and payments to doctors
What Medicare Part D paid pharmacies for Ixempra, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.
Was your doctor paid by R-pharm US LLC?
R-pharm US LLC reported the most payments naming Ixempra. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $87K
- Providers
- 62
- Transactions
- 155
- Average per transaction
- $564
The per-transaction average — $564 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 62 providers the average total is $1,409, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| R-pharm US LLC | $87,342 | 100.0% |
| E.r. Squibb & Sons, L.L.C. | $23 | 0.0% |